Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7880)
All Articles published online
|
Publishing Process of This Article
|
May 10, 2013 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singh S, Singh PP. Statin a day keeps cancer at bay. World J Clin Oncol 2013; 4(2): 43-46 [PMID: 23696961 DOI: 10.5306/wjco.v4.i2.43] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v4/i2/43.htm |
| Number | Citing Articles |
| 1 |
Mary L. Hardy, Karen Duvall. Multivitamin/multimineral supplements for cancer prevention: implications for primary care practice. Postgraduate Medicine 2015; 127(1): 107 doi: 10.1080/00325481.2015.993284
|
| 2 |
Rafael Simó, Oleguer Plana-Ripoll, Diana Puente, Rosa Morros, Xavier Mundet, Luz M. Vilca, Cristina Hernández, Inmaculada Fuentes, Adriana Procupet, Josep M. Tabernero, Concepción Violán, Amar Abderrahmani. Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control Study. PLoS ONE 2013; 8(11): e79968 doi: 10.1371/journal.pone.0079968
|
| 3 |
Baoge Qu, Hao Qu. The Influence of Statins on Risk and Patient Survival in Colorectal Cancer. Journal of Clinical Gastroenterology 2019; 53(9): 699 doi: 10.1097/MCG.0000000000000844
|
| 4 |
Tina Fransgaard, Lau Caspar Thygesen, Ismail Gögenur. Statin use is not associated with improved 30-day survival in patients undergoing surgery for colorectal cancer. International Journal of Colorectal Disease 2018; 33(2): 199 doi: 10.1007/s00384-017-2947-9
|
| 5 |
Behzad Yeganeh, Emilia Wiechec, Sudharsana R. Ande, Pawan Sharma, Adel Rezaei Moghadam, Martin Post, Darren H. Freed, Mohammad Hashemi, Shahla Shojaei, Amir A. Zeki, Saeid Ghavami. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacology & Therapeutics 2014; 143(1): 87 doi: 10.1016/j.pharmthera.2014.02.007
|
| 6 |
Jing-Yang Huang, Zhi-Hong Jian, Oswald Ndi Nfor, Kai-Ming Jhang, Wen-Yuan Ku, Pei-Chieh Ko, Shiou-Rung Jan, Chien-Chang Ho, Chia-Chi Lung, Hui-Hsien Pan, Yu-Chiu Liang, Yung-Po Liaw, Yuanpu Peter Di. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma. PLOS ONE 2015; 10(7): e0133367 doi: 10.1371/journal.pone.0133367
|
| 7 |
I. Vasiliadis, G. Kolovou, D. P. Mikhailidis. Cardiotoxicity and Cancer Therapy. Angiology 2014; 65(5): 369 doi: 10.1177/0003319713498298
|
| 8 |
Pilar Mazón Ramos. Del concepto de estatinas de alta potencia a los efectos extralipídicos de las estatinas. Revista Española de Cardiología Suplementos 2015; 15: 22 doi: 10.1016/S1131-3587(15)70121-4
|
| 9 |
Tingting Wang, Serena Seah, Xinyi Loh, Ching-Wan Chan, Mikael Hartman, Boon-Cher Goh, Soo-Chin Lee. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway. Oncotarget 2016; 7(3): 2532 doi: 10.18632/oncotarget.6304
|
| 10 |
Patricia A.J. Muller, Karen H. Vousden. Mutant p53 in Cancer: New Functions and Therapeutic Opportunities. Cancer Cell 2014; 25(3): 304 doi: 10.1016/j.ccr.2014.01.021
|
| 11 |
Yong Zhang, Weijia Kong, Jiandong Jiang. Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms. Science China Life Sciences 2017; 60(6): 601 doi: 10.1007/s11427-017-9047-4
|